Polomar Health Services, Inc. (PMHS) — SEC Filings

Polomar Health Services, Inc. (PMHS) — 38 SEC filings. Latest: 8-K (Dec 12, 2025). Includes 22 8-K, 6 10-Q, 2 S-1/A.

View Polomar Health Services, Inc. on SEC EDGAR

Overview

Polomar Health Services, Inc. (PMHS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 12, 2025: On December 8, 2025, Polomar Health Services, Inc. entered into a material definitive agreement. The company, formerly known as Trustfeed Corp. and HEALTHMED SERVICES LTD, is incorporated in Nevada and headquartered in Palm Harbor, Florida.

Sentiment Summary

Across 38 filings, the sentiment breakdown is: 6 bearish, 29 neutral, 3 mixed. The dominant filing sentiment for Polomar Health Services, Inc. is neutral.

Filing Type Overview

Polomar Health Services, Inc. (PMHS) has filed 22 8-K, 2 S-1/A, 6 10-Q, 1 S-1, 2 10-K, 1 10-Q/A, 2 8-K/A, 1 SC 13D/A, 1 SC 13D with the SEC between Jan 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent SEC Filings (38)

Polomar Health Services, Inc. SEC Filing History
DateFormDescriptionRisk
Dec 12, 20258-KPolomar Health Services Enters Material Definitive Agreementmedium
Dec 8, 2025S-1/APolomar Health Services Files S-1/A, Details Share Issuances & Costsmedium
Dec 5, 2025S-1/APolomar Health Shifts to Telehealth, Faces Losses Amidst Strategic Pivothigh
Nov 25, 202510-QPolomar Health Services' Net Loss Triples Amid Business Model Shifthigh
Oct 14, 20258-KPolomar Health Services Signs Material Definitive Agreementmedium
Sep 15, 2025S-1Polomar Health Services Registers 5.1M Shares for Resale, Eyes Telehealth Expansionhigh
Aug 29, 20258-KPolomar Health Services Enters Material Definitive Agreementmedium
Aug 19, 202510-QPolomar Health Services Files Q2 2025 10-Qlow
Jul 29, 20258-KPolomar Health Services Enters Material Definitive Agreementmedium
Jul 25, 20258-KPolomar Health Services Enters Material Definitive Agreementmedium
Jul 24, 20258-KPolomar Health Services Signs Material Agreementmedium
Jul 9, 20258-KPolomar Health Services Files 8-K with Key Agreements and Equity Salesmedium
Jun 30, 202510-QPolomar Health Services Posts Q1 Loss Amid Stagnant Growthhigh
May 22, 202510-KPolomar Health Swings to Loss Amid 06 Technology Mergerhigh
Apr 16, 20258-KPolomar Health Services Announces Board and Compensation Changeslow
Mar 17, 20258-KPolomar Health Services Files Material Definitive Agreementmedium
Mar 7, 202510-Q/APolomar Health Services Files 10-Q/A Amendmentlow
Mar 5, 20258-KPolomar Health Services Restates Financialshigh
Jan 14, 20258-KPolomar Health Services Enters Material Definitive Agreementmedium
Nov 19, 202410-QPolomar Health Services Files Q3 2024 10-Qmedium

Risk Profile

Risk Assessment: Of PMHS's 36 recent filings, 6 were flagged as high-risk, 21 as medium-risk, and 9 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Polomar Health Services, Inc. Financial Summary (10-Q, Nov 25, 2025)
MetricValue
Revenue$16,174
Net Income-$1,712,193
EPSN/A
Debt-to-EquityN/A
Cash Position$38,854
Operating MarginN/A
Total Assets$9,269,726
Total Debt$1,503,130

Key Executives

  • Terrence M. Tierney
  • Stephen E. Fox, Esq.
  • Samantha M. Guido, Esq.
  • Daniel Gordon

Industry Context

The health services industry is highly regulated and competitive, with companies often seeking capital to fund operations, acquisitions, and expansion. Trends include consolidation, technological integration, and evolving reimbursement models. Companies like Polomar Health Services operate within this dynamic environment, requiring strategic financial management and compliance.

Top Tags

material-definitive-agreement (7) · material-agreement (6) · corporate-governance (6) · company-name-change (4) · 10-Q (4) · financials (4) · amendment (4) · corporate-actions (3) · Compounding Pharmacy (3) · Telehealth (3)

Key Numbers

Polomar Health Services, Inc. Key Metrics
MetricValueContext
Total estimated expenses for issuance and distribution$30,000.00Includes SEC fees, accounting, and legal expenses for the offering.
SEC registration fee$860.83Specific cost for filing the S-1/A.
Accounting fees and expenses$10,000.00Estimated cost for accounting services related to the offering.
Legal fees and expense$15,000.00Estimated cost for legal services related to the offering.
Shares of Common Stock issued to CWR10,000,000Issued on September 12, 2024, upon conversion of Series A Preferred Stock.
Shares of Common Stock issued to former Polomar members207,414,147Issued as of September 30, 2024, in connection with an acquisition.
Shares of Common Stock7,710,219Number of shares offered for resale by selling stockholders
Fixed Price Per Share$0.20Price at which selling stockholders may sell shares until listed on an exchange
Last Reported Closing Bid Price$0.08PMHS common stock price on OTCID Basic Market as of December 5, 2025
States Licensed30Number of states Polomar Pharmacy is currently licensed to deliver compounded medications
Launch Year2026Expected launch year for SlimRx™ platform
Launch QuarterQ1 2026Expected launch quarter for PoloMeds™ platform
Agreement DateSeptember 26, 2025Date of pharmacy services agreement with CareValidate, Inc.
Fulfillment Start DateOctober 6, 2025Date Polomar began fulfilling prescriptions for CareValidate
Consideration for CWR Transaction$350,000Aggregate consideration paid by CWR 1, LLC for Transferred Shares

Related Companies

PLMR

Frequently Asked Questions

What are the latest SEC filings for Polomar Health Services, Inc. (PMHS)?

Polomar Health Services, Inc. has 38 recent SEC filings from Jan 2024 to Dec 2025, including 22 8-K, 6 10-Q, 2 S-1/A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of PMHS filings?

Across 38 filings, the sentiment breakdown is: 6 bearish, 29 neutral, 3 mixed. The dominant sentiment is neutral.

Where can I find Polomar Health Services, Inc. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Polomar Health Services, Inc. (PMHS) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Polomar Health Services, Inc.?

Key financial highlights from Polomar Health Services, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for PMHS?

The investment thesis for PMHS includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Polomar Health Services, Inc.?

Key executives identified across Polomar Health Services, Inc.'s filings include Terrence M. Tierney, Stephen E. Fox, Esq., Samantha M. Guido, Esq., Daniel Gordon.

What are the main risk factors for Polomar Health Services, Inc. stock?

Of PMHS's 36 assessed filings, 6 were flagged high-risk, 21 medium-risk, and 9 low-risk.

What are recent predictions and forward guidance from Polomar Health Services, Inc.?

Forward guidance and predictions for Polomar Health Services, Inc. are extracted from SEC filings as they are enriched.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.